CFO
NGVT icon

Callan Family Office’s Ingevity NGVT Stock Holding History

Callan Family Office’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
14,498
-2,314
-14% -$167K 0.02% 576
2026
Q1 		$1.2M Sell
16,812
-448
-3% -$30.6K 0.03% 510
2025
Q4 		$1.02M Buy
+17,260
New +$937K 0.02% 542

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Callan Family Office's NGVT Position: Q2 2026 in Review

Callan Family Office reduced its Ingevity (NGVT) stake by 14% in Q2 2026, selling an estimated $167K and leaving 14,498 shares worth $1.08M. The position accounts for 0.02% of the portfolio, ranked #576.

Callan Family Office first reported a position in NGVT in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.2M in Q1 2026. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Callan Family Office held 14,498 shares of Ingevity worth $1.08M as of Q2 2026.
  • Callan Family Office sold 2,314 Ingevity shares in Q2 2026, an estimated $167K.
  • Ingevity made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #576 holding.
  • Callan Family Office first reported a position in Ingevity in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Ingevity position peaked at $1.2M in Q1 2026.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.